Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(9;21)(q34;q22)

Clinics and Pathology

Disease Acute myeloid leukaemia (AML)
Epidemiology Only one case to date
Clinics The patient was a 75 year old male patient with a myeloproliferative syndrome (MPS) in transformation to AML. The MPS was a 8p11 myeloproliferative syndrome (EMS)

Cytogenetics

Cytogenetics Morphological The karyotype also comprised a t(8;22)(p11;q11) with BCR/ FGFR fusion, responsible for the EMS

Genes involved and Proteins

Note RUNX1 was involved in the translocation. RUNX1, also called AML1 or CBFA2, is a transcription factor, critical regulator of hematopoietic-cell development, involved in many de novo and treatment related leukaemias.
The exons 1-4 of RUNX1 were fused to repetitive sequences from chromosome 9, adding 70 amino acids to RUNX1 exon 4 encoding sequences, resulting in a truncated RUNX1.
The t(9;21)/RUNX1 involvement may be responsible for the transformation of the EMS.

External links

Other databaset(9;21)(q34;q22) Mitelman database (CGAP - NCBI)
Other databaset(9;21)(q34;q22) CancerChromosomes (NCBI)

To be noted

Additional cases are needed to delineate the epidemiology of this rare entity:
you are welcome to submit a paper to our new Case Report section.

Bibliography

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billstrˆm R, Isaksson M, Strˆmbeck B, Olofsson T, Mitelman F, Johansson B
Genes, chromosomes & cancer. 2001 ; 32 (4) : 302-310.
PMID 11746971
 
Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
Agerstam H, Lilljebjˆrn H, Lassen C, Swedin A, Richter J, Vandenberghe P, Johansson B, Fioretos T
Genes, chromosomes & cancer. 2007 ; 46 (7) : 635-643.
PMID 17394134
 

Contributor(s)

Written02-2008Jean-Loup Huret
Jean Loup HURET, Genetics, Dept Medical Information, University of Poitiers; CHU Poitiers Hospital, F-86021 Poitiers, France

Citation

This paper should be referenced as such :
Huret JL . t(9;21)(q34;q22). Atlas Genet Cytogenet Oncol Haematol. February 2008 .
URL : http://AtlasGeneticsOncology.org/Anomalies/t0921q34q22ID1483.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon May 12 18:12:47 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.